What is Galvus Met 50/1000mg (VILDAGLIPTIN)?
DPP-4 inhibitor for type 2 diabetes. Twice daily dosing. Widely used in Europe and Asia as monotherapy or combined with metformin, sulfonylureas, or insulin.
How it Works
Inhibits DPP-4, preventing degradation of GLP-1 and GIP incretin hormones — increases insulin secretion and decreases glucagon in glucose-dependent manner. No hypoglycemia as monotherapy.
Quick Specs
| Form |
Oral tablets — pre-dosed |
| Shelf Life |
2–3 years (properly stored) |
| Storage |
Room temperature (15–25°C), cool dry place |
| Brand |
Pharma |
| Pack Size |
105 tablets |
| Dose per Tablet |
1000MG |
Frequently Asked Questions
🧪 Peptide Research Tools: Use QSC's free
peptide calculators — reconstitution, BAC water, dosing, half-life, and mixing charts.
🌍 Domestic shipping: 🇺🇸 USA 5–7 days
🌏 International shipping: 7–14 days
⚠️ RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION
QSC products are strictly for in vitro and in vivo laboratory research.
Safety & Handling
🚫
Not for Human Use
These compounds are for research only.
🥽
PPE Required
Always use appropriate protective equipment.
❄️
Storage Compliance
Follow product-specific storage conditions.
Product-Specific Storage
Room temperature (15–25°C), cool dry place